Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biomarin Pharmaceuticals (NQ: BMRN )

64.31 +0.86 (+1.36%)
Streaming Delayed Price Updated: 1:40 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biomarin Pharmaceuticals

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HNST, BMRN and AMRN
NEW YORK, NY / ACCESSWIRE / November 7, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to... 
From The Klein Law Firm
Via AccessWire
Topics Fraud Initial Public Offering Intellectual Property
Exposures COVID-19 Financial Intellectual Property
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BioMarin Pharmaceutical Inc. Investors to Secure Counsel Before Important December 22 Deadline in Securities Class Action – BMRN
From Rosen Law Firm
Via Business Wire
SHAREHOLDER ALERT: ZEV BMRN RECAF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / November 5, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a... 
From The Law Offices of Vincent Wong
Via AccessWire
Topics Fraud
Exposures Legal
INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
LAWSUITS FILED AGAINST APPH, BMRN and RECAF - Jakubowitz Law Pursues Shareholders Claims
NEW YORK, NY / ACCESSWIRE / November 5, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies... 
From Jakubowitz Law
Via AccessWire
Topics Fraud Lawsuit
Exposures Financial Legal
CLASS ACTION UPDATE for SAM, HNST and BMRN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / November 5, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Initial Public Offering Lawsuit
Exposures COVID-19 Financial Legal
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
CLASS ACTION UPDATE for WDH, HEPS and BMRN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / November 4, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HNST, HEPS and BMRN
NEW YORK, NY / ACCESSWIRE / November 4, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to... 
From The Klein Law Firm
Via AccessWire
Topics Fraud Initial Public Offering Lawsuit
Exposures COVID-19 Financial Legal
SHAREHOLDER ALERT: BMRN AMRN RECAF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / November 4, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a... 
From The Law Offices of Vincent Wong
Via AccessWire
Topics Fraud Intellectual Property
Exposures Intellectual Property Legal
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
LAWSUITS FILED AGAINST BMRN, AMRN and CEI - Jakubowitz Law Pursues Shareholders Claims
NEW YORK, NY / ACCESSWIRE / November 3, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies... 
From Jakubowitz Law
Via AccessWire
Topics Fraud Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HNST, BMRN and HMLP
NEW YORK, NY / ACCESSWIRE / November 3, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to... 
From The Klein Law Firm
Via AccessWire
Topics Fraud Initial Public Offering Lawsuit
Exposures COVID-19 Financial Legal
SHAREHOLDER ALERT: BMRN AMRN HMLP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / November 3, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a... 
From The Law Offices of Vincent Wong
Via AccessWire
Topics Fraud Intellectual Property
Exposures COVID-19 Intellectual Property Legal
Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
The loaded Prescription Drug User Fee Act (PDUFA) calendar for October produced mixed outcomes. PDUFA dates are key binary events for biotech stocks that can move the needle in a... 
Via Benzinga
SHAREHOLDER ALERT: Robbins LLP Announces that BioMarin Pharmaceutical Inc. (BMRN) is Being Sued for Misleading Shareholders
From Robbins LLP
Via Business Wire
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of APPH, BMRN and AMRN
NEW YORK, NY / ACCESSWIRE / October 31, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies.... 
From The Gross Law Firm
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
ALERT: BioMarin Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – BMRN
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of NNOX, BMRN and RECAF
NEW YORK, NY / ACCESSWIRE / October 29, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to... 
From The Klein Law Firm
Via AccessWire
Topics Fraud Lawsuit
Exposures Financial Legal
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SAM, BMRN and AMRN
NEW YORK, NY / ACCESSWIRE / October 29, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly-traded companies.... 
From The Gross Law Firm
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HYZN, INNV and BMRN
NEW YORK, NY / ACCESSWIRE / October 28, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies.... 
From The Gross Law Firm
Via AccessWire
Topics Lawsuit
Exposures Financial Legal Product Safety
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HYZN, BMRN and AMRN
NEW YORK, NY / ACCESSWIRE / October 28, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies.... 
From The Gross Law Firm
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
BioMarin's Q3 Net Income Hit By Lower Product Sales
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) reported a 14% Y/Y decrease in Q3 revenue to $408.7 million, missing the consensus estimate of $435.32 million. The decline... 
Via Benzinga
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ZEV, BMRN and AMRN
AMRN The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss,... 
From The Klein Law Firm
Via AccessWire
Topics Fraud Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
BioMarin Pharmaceutical inc (BMRN) Q3 2021 Earnings Call Transcript
BMRN earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
BMRN ALERT: Robbins Geller Rudman & Dowd LLP Announces that BioMarin Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO, CA / ACCESSWIRE / October 27, 2021 / The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) securities between... 
From Robbins Geller Rudman & Dowd LLP
Via AccessWire
Topics Lawsuit
Exposures Financial Legal Product Safety
BIOMARIN ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against BioMarin Pharmaceuticals and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Lawsuits Filed Against SAM, BMRN and RECAF - Jakubowitz Law Pursues Shareholders Claims
NEW YORK, NY / ACCESSWIRE / October 27, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies... 
From Jakubowitz Law
Via AccessWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Biomarin Pharmaceutical: Q3 Earnings Insights
Biomarin Pharmaceutical (NASDAQ:BMRN) reported its Q3 earnings results on Wednesday, October 27, 2021 at 04:05 PM. Here's what investors need to know about the announcement.... 
Via Benzinga
SHAREHOLDER ALERT: INNV HEPS BMRN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / October 27, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a... 
From The Law Offices of Vincent Wong
Via AccessWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.